2008 - Factores de crecimiento hematopoyético-Dr. A. Biete - GICOR
2008 - Factores de crecimiento hematopoyético-Dr. A. Biete - GICOR
2008 - Factores de crecimiento hematopoyético-Dr. A. Biete - GICOR
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Overall, epoetin treatment shows a trend<br />
towards an improvement in survival<br />
Study<br />
Abels 1993<br />
Cascinu 1994<br />
Case 1993<br />
Cazzola 1995<br />
Coiffier 2001<br />
Dammacco 2001<br />
Del Maestro 1997<br />
Dunphy 1999<br />
Henry 1995<br />
Kurz 1997<br />
Littlewood 2001<br />
Oberhoff 1998<br />
Rose 1994<br />
Ten Bokkel Huinink 1998<br />
Thatcher 1999a<br />
Thatcher 1999b<br />
Thompson 2000<br />
Throuvalas 2000<br />
Österborg 1996<br />
Österborg 1996<br />
Österborg 2002<br />
TOTAL (OR = 0.81)<br />
Test for heterogeneity<br />
chi-square=14.49: df=18 p=0.6966<br />
Test for overall effect= –2.07 p=0.04<br />
Odds ratio (OR) (95% CI)<br />
Favours epoetin Favours control<br />
0.01 0.1 1 10 100<br />
Risk ratio<br />
Not including<br />
He<strong>de</strong>nus 2002,<br />
He<strong>de</strong>nus 2003,<br />
Kotasek 2003,<br />
Vansteenkiste 2002,<br />
Lleyland-Jones 2003,<br />
and Henke 2003<br />
Bohlius et al. Cochrane Database<br />
Syst Rev. 2004; (3): CD003407<br />
Also JNCI 2005
Change language